STEPHEN M. KANOVSKY - 10 Aug 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
10 Aug 2024
Net transactions value
$0
Form type
4
Filing time
13 Aug 2024, 16:27:52 UTC
Previous filing
04 Jun 2024
Next filing
09 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $0 +11,336 +46% $0.000000 36,090 10 Aug 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Restricted Stock Unit Options Exercise $0 -11,336 -100% $0.000000* 0 10 Aug 2024 Common Stock 11,336 $0.000000 Direct F2
holding NEO Stock Option (Right to Buy) 4,269 10 Aug 2024 Common Stock 4,269 $22.52 Direct
holding NEO Stock Option (Right to Buy) 3,448 10 Aug 2024 Common Stock 3,448 $28.54 Direct
holding NEO Stock Option (Right to Buy) 3,714 10 Aug 2024 Common Stock 3,714 $40.90 Direct
holding NEO Stock Option (Right to Buy) 13,882 10 Aug 2024 Common Stock 13,882 $8.10 Direct
holding NEO Stock Option (Right to Buy) 8,353 10 Aug 2024 Common Stock 8,353 $14.82 Direct
holding NEO Stock Option (Right to Buy) 8,672 10 Aug 2024 Common Stock 8,672 $13.71 Direct
holding NEO Restricted Stock Unit 12,254 10 Aug 2024 Common Stock 12,254 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects release of restricted stock units that were previously reported on a Form 4.
F2 Once vested, the shares of common stock are not subject to expiration.